Table 1.
n | Paired couples | TJSI | AJI | RCT |
---|---|---|---|---|
1 | Acyclovir vs doscarnet | + | + | + |
2 | Buprenorphine vs alfentanil | + | ||
3 | Captopril vs moexipril | + | + | + |
4 | Diltiazem vs felodipine | + | + | |
5 | Enalapril vs Perindopril | + | + | + |
6 | Fluoxetine vs maprotiline | + | + | + |
7 | Gemfibrozil vs fenofibrate | + | ||
8 | Lovastatin vs fluvastatin | + | + | |
9 | Omeprazole vs lansoprazole | + | + | |
10 | Zidovudine vs abacavir | + | + | |
Distinguishability from random chance | 100% | 80% | 40% | |
95% Cl | 69%–100% | 44%–98% | 12%–74% |
Note: Plus indicates when the index for the breakthrough drug was higher than that of the compared drug in a couple.
Abbreviations: Cl, confidence interval; TJSI, Top Journals Selectivity Index; AJI, All Journals Index; RCT, randomized controlled trials.